These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11119809)

  • 21. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin.
    Gutiérrez CA; Chaparro C; Krajden M; Winton T; Kesten S
    Chest; 1998 Apr; 113(4):924-32. PubMed ID: 9554627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning.
    Keven K; Basu A; Tan HP; Thai N; Khan A; Marcos A; Starzl TE; Shapiro R
    Transplant Proc; 2004 Dec; 36(10):3107-12. PubMed ID: 15686707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia.
    Villa M; Lage E; Ballesteros S; Cañas E; Sánchez M; Ordóñez A; Borrego JM; Hinojosa R; Cisneros JM
    Transplant Proc; 2003 Mar; 35(2):732-4. PubMed ID: 12644115
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G
    Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation.
    Waid TH; McKeown JW
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):46. PubMed ID: 7482820
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
    Tenschert W; Gonnermann D; Meyer-Moldenhauer WH; Cremaschi L; Huland H
    Transplant Proc; 1993 Dec; 25(6):3256-8. PubMed ID: 8266533
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
    Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M
    Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
    Sola E; Vega E; Gutiérrez C; López V; Cabello M; Burgos D; González Molina M; Siles J
    Nefrologia; 2009; 29(2):180-1. PubMed ID: 19396331
    [No Abstract]   [Full Text] [Related]  

  • 30. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of valganciclovir plus cytomegalovirus immune globulin for prevention of cytomegalovirus disease in high-risk renal transplant recipients.
    Maldonado AQ; Bitterman AN; Ojogho ON; Bowen KA; Weeks DL
    Ann Pharmacother; 2014 Apr; 48(4):548-9. PubMed ID: 24658636
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis and treatment of cytomegalovirus infection after renal transplantation.
    Guandelin M; Xiuwu H; Juzhong G; Juanjun X; Zhiyou H
    Transplant Proc; 2000 Nov; 32(7):1930-1. PubMed ID: 11120006
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
    Kowalsky S; Arnon R; Posada R
    Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients.
    Díaz-Pedroche C; Lumbreras C; Del Valle P; San Juan R; Hernando S; Folgueira D; Andrés A; Delgado J; Meneu JC; Morales JM; Moreno E; Aguado JM
    Transplant Proc; 2005 Nov; 37(9):3766-7. PubMed ID: 16386532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies in lung transplantation: management of cytomegalovirus infections.
    Zamora MR
    J Heart Lung Transplant; 2002 Aug; 21(8):841-9. PubMed ID: 12163083
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytomegalovirus-associated haemophagocytic syndrome in a kidney transplant patient].
    Bea Granell S; Beneyto Castello I; Ramos Escorihuela D; Sánchez Plumed J; Sánchez Pérez P; Hernández-Jaras J; Rivas S
    Nefrologia; 2011; 31(2):236-8. PubMed ID: 21461026
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of cytomegalovirus prophylaxis in renal retransplantation.
    Singh TP; Gruber SA; Lempert N; Freed B; Conti DJ
    Transplant Proc; 1995 Feb; 27(1):964-5. PubMed ID: 7879247
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation.
    Ciancio G; Burke GW; Mattiazzi A; Leibovici Z; Dowdy L; Roth D; Kupin W; Rosen A; Jorge D; Cirocco RE; Miller J
    Clin Transplant; 2004 Aug; 18(4):402-6. PubMed ID: 15233817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus disease with Guillain-Barré syndrome in a cadaver renal allograft recipient: cause or coincidence.
    Keithi-Reddy SR; Chakravarthi RM; Hussaini SM; Venkatapuram RR; Murthy JM
    Int Urol Nephrol; 2007; 39(3):967-70. PubMed ID: 17450421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.